PH
Paul Herzich
Chief Technology Officer

Paul Herzich insider trades: Solid Biosciences (SLDB) stock sales

Chief Technology Officer, Solid Biosciences Last trade Feb 18, 2026 11 Form 4 filings
$274K
Sold, last 12 months
4 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2023
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Paul reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 18, 2026SLDB↓ Sell$21K
Feb 4, 2026SLDB↓ Sell$70K
Feb 2, 2026SLDB↓ Sell$169K
Dec 3, 2025SLDB↓ Sell$14K
Feb 14, 2025SLDB↓ Sell$11K
Dec 3, 2024SLDB↓ Sell$16K
Dec 4, 2023SLDB↓ Sell10b5-1$8K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SLDB insiders

Open-market trades in the last 12 months

About Paul Herzich's insider trades

Paul Herzich is Chief Technology Officer at Solid Biosciences (SLDB). Since Dec 4, 2023, Paul has reported no open-market purchases and 7 sales worth $309K on SEC Form 4. In the last 12 months: 4 sales ($274K).

1 sale (3% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include option exercises (6 filings), grants and awards (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SLDB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.